Documents

A list of downloadable documents created during development.

Osteoporosis - secondary prevention including strontium ranelate: final appraisal determination 3

Osteoporosis - secondary prevention including strontium ranelate: final appraisal determination 2

Osteoporosis - primary and secondary prevention: appeal announcement

Osteoporosis - primary and secondary prevention: notice of appeal

Osteoporosis - secondary prevention including strontium ranelate: final appraisal determination

Osteoporosis - secondary prevention including strontium ranelate: decision support unit specification

Osteoporosis - secondary prevention including strontium ranelate: appraisal update to consultees and commentators

Osteoporosis - secondary prevention including strontium ranelate: appeal panel decision letter

Osteoporosis - secondary prevention including strontium ranelate: appeal documents

Osteoporosis - secondary prevention including strontium ranelate: appeal against the clinical and cost effectiveness of technologies for the primary and secondary prevention of osteoporosis

Osteoporosis - secondary prevention including strontium ranelate: appeal letter to consultees and commentators

Osteoporosis - secondary prevention including strontium ranelate: letter to consultees and commentators about the link of FAD to technology appraisal TA87

Osteoporosis - secondary prevention including strontium ranelate: appraisal consultation (February 2007)

Osteoporosis - secondary prevention including strontium ranelate: letter sent to consultees and commentators regarding the delay to the release of the FAD

Osteoporosis - secondary prevention including strontium ranelate: appraisal consultation (September 2006)

Osteoporosis - secondary prevention including strontium ranelate: decision support unit project specification letter

Osteoporosis - secondary prevention including strontium ranelate: decision support unit project specification

Osteoporosis - secondary prevention including strontium ranelate: appraisal consultation (September 2005)

Osteoporosis - secondary prevention including strontium ranelate:: letter to consultees and commentators regarding ongoing development

Osteoporosis - secondary prevention including strontium ranelate: final protocol

Osteoporosis - secondary prevention including strontium ranelate: final scope

Osteoporosis - secondary prevention including strontium ranelate: draft scope

Osteoporosis - secondary prevention including strontium ranelate: response to comments on the draft scope

Osteoporosis - secondary prevention including strontium ranelate: response to comments on the provisional matrix

2004/027 NICE asked to develop guidance on the care of drug misuse, medicines for prostate cancer, and management of attention deficit hyperactivity disorder